In the specialized field of molecular biology and immunology research, the MAGE A3 peptide has emerged as MAGE-A3 is a cancer-testis antigen frequently utilized in immunotherapy research and tumor marker studies, offering valuable insights into cancer biology. a cornerstone for those investigating the mechanisms Among MAGE cancer testis antigens (CTA),MAGE-A3 antigenic peptides represent attractive candidates towards targeted adoptive immunotherapy of cancer. Order SB- of cellular recognition and antigen-specific responses. As a user deeply interested in the biochemical properties of synthetic peptides, I have spent considerable time reviewing how these sequences are utilized in laboratory environments to study the MAGE family of proteins.
Understanding the MAGE A3 Entity
The Melanoma-associated antigen 3 (MAGE-A3) is a protein that in humans is encoded by the MAGEA3 gene. It belongs to the cancer testis family antigens, a group of proteins typically restricted to germ cells in healthy adult tissues but often expressed in various malignant cell lines. Because of this restricted expression pattern, MAGE-A3 is an attractive target for cancer therapy and diagnostic marker development.
When working with these materials, researchers often utilize a Human MAGE-A3 peptide pool. These pools are typically composed of overlapping 15-mer peptides, which are essential for comprehensive epitope mapping. One common product in this space is the MACS GMP PepTivator MAGE-A3, which is designed for efficient in vitro stimulation.
Technical Parameters and Research Applications
In my own review of high-quality materi A multi-epitope "Trojan antigen" ("TA") construct vaccine consisting of human melanoma antigen A3 (MAGE-A3) and human papillomavirus (HPV) 16 peptide als, I have found that the MAGE-A3 (112-120) peptide (KVAELVHFL) serves as a critical reference point. It is a high quality epitope peptide frequently used in T-cell assays. Specifically, this peptide MAGE sequence is often studied for its ability to bind to HLA molecules, such as the HLA-A24 allele, which is vital for understanding how the immune system presents these markers.
Key technical aspects include:
* Synthetic Peptide Construction: High-purity synthetic peptide sequences are necessary to ensure consistency in immunological studies.
* Cytosolic Bioavailability: Recent advancements, such as MAGE-A3 with CPD enhances its cytosolic bioavailability in DCs (dendritic cells), have allowed for more nuanced studies regarding how these antigens are processed internally.
* Combinatorial Research: It is not uncommon to see studies involving MAGE-A3 and NY-ESO-1 peptide combinations, as these multi-antigen approaches provide a broader perspective on how cells react to multiple cancer-testis antigens simultaneously.
Observat MAGEA3 - Melanoma-associated antigen 3 ions on Expression and Immunogenicity
The scientific literature consistently highlights that MAGEA3 expression in mRNA and protein were upregulated in LUAD (lung adenocarcin Apr 1, 2014 — The current review summarizes the information specifically on MAGEA3s DNA\/RNA, protein structure, function and where the gene is implicated. oma) and other tissues. This expression profile makes the study of human melanoma antigen A3 (MAGE-A3) crucial for those mapping the landscape of tumor-specific markers.
Furthermore, MAGEA3 demonstrated T-cell reactivity against highly conserved MAGE-A3 peptides in various preclinical setups. These findings are foundational for researchers aiming to understand the structural requiremen MAGE-A1, MAGE-A3, NY-ESO-1 peptides vaccine ts for T-cell receptor (TCR) binding. It is fascinating to see how the specific amino acid sequences within the A3 protein structure influence the stability of the peptide-MHC complex.
Conclusion for Researchers
For those of us involved A library of cancer testis specific T cell receptors for T in the procurement and analysis of these reagents, it is clear that MAGE-A3 is a cancer-testis antigen of immense significance. Whether you are working with a single peptide sequence for epitope binding or a full library for T-cell stimulation, the quality and purity of the MAGE A3 peptide are paramount. By focusing on these well-defined molecular structures, we continue to gain valuable insights into the complex interactions that define modern immunological research.
*Disclaimer: This article is for informational purposes for researchers and laboratory professionals. It does not constitute medical advice, and these products are not for human use.*